SkinBiotix® - Surface Hygiene

About SkinBioTherapeutics

SkinBioTherapeutics is a publicly-traded biotech focused on harnessing the skin microbiome to develop innovative health solutions. Founded in 2015, its core SkinBiotix® platform has led to the launch of the AxisBiotix-Ps™ supplement for psoriasis and a strategic expansion via acquisitions of Dermatonics and Bio-Tech Solutions. The company pursues a dual-path strategy: generating commercial revenue from consumer and OTC products to fund longer-term R&D ambitions across cosmetic, supplement, medical device, hygiene, and pharmaceutical sectors.

Therapeutic Areas